A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2

被引:107
作者
Dusonchet, Julien
Kochubey, Olexiy [2 ]
Stafa, Klodjan [3 ]
Young, Samuel M., Jr. [4 ]
Zufferey, Romain
Moore, Darren J. [3 ]
Schneider, Bernard L.
Aebischer, Patrick [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Brain Mind Inst, Neurodegenerat Studies Lab, EPFL SV BMI LEN, CH-1015 Lausanne, Switzerland
[2] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland
[3] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland
[4] Max Planck Florida Inst Integrat Biol & Neurosci, Jupiter, FL 33458 USA
基金
瑞士国家科学基金会;
关键词
ADENOVIRAL VECTORS; MICE; EXPRESSION; BRAIN;
D O I
10.1523/JNEUROSCI.5092-10.2011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The G2019S mutation in the leucine-rich repeat kinase 2 (LRRK2) gene is the most common genetic cause of Parkinson's disease (PD), accounting for a significant proportion of both autosomal dominant familial and sporadic PD cases. Our aim in the present study is to generate a mammalian model of mutant G2019S LRRK2 pathogenesis, which reproduces the robust nigral neurodegeneration characteristic of PD. We developed adenoviral vectors to drive neuron-specific expression of full-length wild-type or mutant G2019S human LRRK2 in the nigrostriatal system of adult rats. Wild-type LRRK2 did not induce any significant neuronal loss. In contrast, under the same conditions and levels of expression, G2019S mutant LRRK2 causes a progressive degeneration of nigral dopaminergic neurons. Our data provide a novel rat model of PD, based on a prevalent genetic cause, that reproduces a cardinal feature of the disease within a rapid time frame suitable for testing of neuroprotective strategies.
引用
收藏
页码:907 / 912
页数:6
相关论文
共 21 条
[1]   Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease [J].
Berg, D ;
Schweitzer, KJ ;
Leitner, P ;
Zimprich, A ;
Lichtner, P ;
Belcredi, P ;
Brüssel, T ;
Schulte, C ;
Maass, S ;
Nägele, T ;
Wszolek, ZK ;
Gasser, T .
BRAIN, 2005, 128 :3000-3011
[2]   Localization of LRRK2 to membranous and vesicular structures in mammalian brain [J].
Biskup, Saskia ;
Moore, Darren J. ;
Celsi, Fulvio ;
Higashi, Shinji ;
West, Andrew B. ;
Andrabi, Shaida A. ;
Kurkinen, Kaisa ;
Yu, Seong-Woon ;
Savitt, Joseph M. ;
Waldvogel, Henry J. ;
Faull, Richard L. M. ;
Emson, Piers C. ;
Torp, Reldun ;
Ottersen, Ole P. ;
Dawson, Ted M. ;
Dawson, Valina L. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :557-569
[3]  
Di Fonzo A, 2005, LANCET, V365, P412
[4]   Biochemical and pathological characterization of Lrrk2 [J].
Giasson, BI ;
Covy, JP ;
Bonini, NM ;
Hurtig, HI ;
Farrer, MJ ;
Trojanowski, JQ ;
Van Deerlin, VM .
ANNALS OF NEUROLOGY, 2006, 59 (02) :315-322
[5]   Common LRRK2 mutation in idiopathic Parkinson's disease [J].
Gilks, WP ;
Abou-Sleiman, PM ;
Gandhi, S ;
Jain, S ;
Singleton, A ;
Lees, AJ ;
Shaw, K ;
Bhatia, KP ;
Bonifati, V ;
Quinn, NP ;
Lynch, J ;
Healy, DG ;
Holton, JL ;
Revesz, T ;
Wood, NW .
LANCET, 2005, 365 (9457) :415-416
[6]   Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study [J].
Healy, Daniel G. ;
Falchi, Mario ;
O'Sullivan, Sean S. ;
Bonifati, Vincenzo ;
Durr, Alexandra ;
Bressman, Susan ;
Brice, Alexis ;
Aasly, Jan ;
Zabetian, Cyrus P. ;
Goldwurm, Stefano ;
Ferreira, Joaquim J. ;
Tolosa, Eduardo ;
Kay, Denise M. ;
Klein, Christine ;
Williams, David R. ;
Marras, Connie ;
Lang, Anthony E. ;
KWszolek, Zbigniew ;
Berciano, Jose ;
Schapira, Anthony H. V. ;
Lynch, Timothy ;
Bhatia, Kailash P. ;
Gasser, Thomas ;
Lees, Andrew J. ;
Wood, Nicholas W. .
LANCET NEUROLOGY, 2008, 7 (07) :583-590
[7]   Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area [J].
Kügler, S ;
Kilic, E ;
Bähr, M .
GENE THERAPY, 2003, 10 (04) :337-347
[8]   Neuron-specific expression of therapeutic proteins:: Evaluation of different cellular promoters in recombinant adenoviral vectors [J].
Kügler, S ;
Meyn, L ;
Holzmüller, H ;
Gerhardt, E ;
Isenmann, S ;
Schulz, JB ;
Bähr, M .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 17 (01) :78-96
[9]   Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease [J].
Lee, Byoung Dae ;
Shin, Joo-Ho ;
VanKampen, Jackalina ;
Petrucelli, Leonard ;
West, Andrew B. ;
Ko, Han Seok ;
Lee, Yun-Il ;
Maguire-Zeiss, Kathleen A. ;
Bowers, William J. ;
Federoff, Howard J. ;
Dawson, Valina L. ;
Dawson, Ted M. .
NATURE MEDICINE, 2010, 16 (09) :998-1000
[10]   LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs [J].
Lesage, S ;
Dürr, A ;
Tazir, M ;
Lohmann, E ;
Leutenegger, AL ;
Janin, S ;
Pollak, P ;
Brice, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :422-423